About ICON
ICON is a company based in Dublin (Ireland) founded in 1990. It operates as a Professional Services and Managed Services. The company has 41,900 employees as of December 31, 2024. ICON has completed 18 acquisitions, including Aptiv Solutions, ClinicalRM and Firecrest Clinical. ICON offers products and services including Clinical Research Solutions, Consulting Services, and Technology Solutions. ICON operates in a competitive market with competitors including Medpace, Lambda Therapeutic, JCCT, Dhiti Life Sciences and Diacrin, among others.
- Headquarter Dublin, Ireland
- Employees 41900 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Icon Plc
-
Annual Revenue
$8.28 B (USD)1.99as on Dec 31, 2024
-
Net Profit
$791.47 M (USD)29.26as on Dec 31, 2024
-
EBITDA
$1.73 B (USD)2.58as on Dec 31, 2024
-
Latest Funding Round
$4.69 M (USD), Grant
Sep 22, 2021
-
Investors
Enterprise Ireland
& 1 more
-
Employee Count
41900
as on Dec 31, 2024
-
Investments & Acquisitions
Aptiv Solutions
& 17 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ICON
ICON is a publicly listed company on the NASDAQ with ticker symbol ICLR in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ICON
ICON offers a comprehensive portfolio of products and services, including Clinical Research Solutions, Consulting Services, and Technology Solutions.
Services for drug development are provided by ICON.
Strategic consulting for asset development is offered here.
Technology solutions for clinical research are developed comprehensively.
People of ICON
Unlock access to complete
Software Development Team
186 people
Senior Team
180 people
Leadership Team
146 people
Clinical Team
101 people
Data Analysis and Operations Team
71 people
Operations Team
66 people
Sales and Marketing
40 people
Finance and Accounting
36 people
Unlock access to complete
Funding Insights of ICON
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $4.7M
-
First Round
First Round
(01 Sep 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Grant - ICON | Valuation |
investors |
|
| Jul, 2018 | Amount | Grant - ICON | Valuation |
investors |
|
| Jan, 2018 | Amount | Grant - ICON | Valuation |
investors |
Investors in ICON
ICON has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Enterprise Ireland and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Support is provided to Irish manufacturing and service sector businesses.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
Investments & Acquisitions by ICON
ICON has strategically engaged in corporate development activities, having acquired 18 companies. Notable acquisitions include Aptiv Solutions, ClinicalRM and Firecrest Clinical.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
HumanFirst is integrated into ICON, focusing on digital health solutions.
|
2017 | ||||
|
Provider of market access solutions for the biopharmaceutical and medical device industries
|
2015 | ||||
|
Tax credits are identified, calculated, and processed for businesses.
|
2010 |
Financial Statements - ICON
Icon Comparisons
Competitors of ICON
ICON operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medpace, Lambda Therapeutic, JCCT, Dhiti Life Sciences and Diacrin, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A range of clinical research services is offered by Medpace.
|
|
| domain | founded_year | HQ Location |
CRO with operations in India, US, Poland, Canada and UK. Winner of Frost & Sullivan 'CRO of the Year' - 2010
|
|
| domain | founded_year | HQ Location |
CRO focused on early & end stage clinical trial services
|
|
| domain | founded_year | HQ Location |
Biotechnology company offering in vitro diagnostic products for healthcare sector
|
|
| domain | founded_year | HQ Location |
Educational programs are provided by Diacrin since 1989.
|
|
| domain | founded_year | HQ Location |
Performs clinical research trials to evaluate investigational drugs and devices.
|
Frequently Asked Questions about ICON
ICON was founded in 1990 and raised its 1st funding round 25 years after it was founded.
ICON is headquartered in Dublin, Ireland.
As of Dec 31, 2024, the latest employee count at ICON is 41,900.
Annual revenue of ICON is $8.28B as on Dec 31, 2024.
ICON plc is recognized as a leading Contract Research Organization (CRO) focused on clinical research and drug development. Services are provided across various sectors including biotechnology, pharmaceuticals, medical devices, and public health. Comprehensive solutions are offered, ranging from early-phase trials to post-marketing support. Specialized therapeutic expertise is delivered in areas such as oncology, cardiovascular, and rare diseases. Innovative technologies and patient-centric approaches are integrated to enhance trial efficiency. Strategic consulting and real-world intelligence are also provided to optimize RD outcomes for clients globally.
ICON's top competitors include Medpace, Lambda Therapeutic and Dhiti Life Sciences.
ICON offers Clinical Research Solutions, Consulting Services, and Technology Solutions.
Yes, ICON is publicly traded on NASDAQ under the ticker symbol ICLR.
ICON has made 18 acquisitions, including Aptiv Solutions, ClinicalRM, and Firecrest Clinical.
ICON has 2 investors. Key investors include Enterprise Ireland, and European Union.
The ticker symbol of ICON is ICLR on NASDAQ.